Literature DB >> 19460940

A tumor sorting protocol that enables enrichment of pancreatic adenocarcinoma cells and facilitation of genetic analyses.

Zachary S Boyd1, Rajiv Raja, Stephanie Johnson, David A Eberhard, Mark R Lackner.   

Abstract

Molecular profiling of human cancer is complicated by both stromal contamination and cellular heterogeneity within samples from tumor biopsies. In this study, we developed a tissue-processing protocol using mechanical dissociation and flow cytometric sorting that resulted in the respective enrichment of stromal and tumor fractions from frozen pancreatic adenocarcinoma samples. Molecular profiling of DNA from the sorted populations using high-density single nucleotide polymorphism arrays revealed widespread chromosomal loss of heterozygosity in tumor fractions but not in either the stromal fraction or unsorted tissue specimens from the same sample. Similarly, a combination of KRAS mutations and chromosomal copy number changes at key pancreatic cancer loci, such as CDK2NA and TP53, was detected in a substantial proportion of the tumor fractions but not in matched stromal fractions from the same sample. This approach to tissue processing could greatly expand the amount of archived tissue that is available for molecular profiling of human cancer and enable a more accurate diagnosis of genetic alterations in patient samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460940      PMCID: PMC2710704          DOI: 10.2353/jmoldx.2009.080124

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  31 in total

1.  Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer.

Authors:  Elizabeth L Schubert; Li Hsu; Laura A Cousens; Jeri Glogovac; Steve Self; Brian J Reid; Peter S Rabinovitch; Peggy L Porter
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Targeted therapy in oncology: the agony and ecstasy of personalized medicine.

Authors:  J S Ross; B Greene
Journal:  Expert Rev Anticancer Ther       Date:  2001-10       Impact factor: 4.512

3.  An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

Authors:  Xiaojun Zhao; Cheng Li; J Guillermo Paez; Koei Chin; Pasi A Jänne; Tzu-Hsiu Chen; Luc Girard; John Minna; David Christiani; Chris Leo; Joe W Gray; William R Sellers; Matthew Meyerson
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 4.  BRCA2 and pancreatic cancer.

Authors:  Ali Naderi; Fergus J Couch
Journal:  Int J Gastrointest Cancer       Date:  2002

5.  Mutation detection in KRAS Exon 1 by constant denaturant capillary electrophoresis in 96 parallel capillaries.

Authors:  Jens Bjørheim; Marek Minarik; Gustav Gaudernack; Per Olaf Ekstrøm
Journal:  Anal Biochem       Date:  2002-05-15       Impact factor: 3.365

Review 6.  Pancreatic cancer biology and genetics.

Authors:  Nabeel Bardeesy; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

Review 7.  Cyclins and breast cancer.

Authors:  Robert L Sutherland; Elizabeth A Musgrove
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

8.  Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.

Authors:  Jan Franko; Alyssa M Krasinskas; Marina N Nikiforova; Narcis O Zarnescu; Kenneth K W Lee; Steven J Hughes; David L Bartlett; Herbert J Zeh; A James Moser
Journal:  J Gastrointest Surg       Date:  2008-08-02       Impact factor: 3.452

9.  BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.

Authors:  Eric S Calhoun; Jessa B Jones; Raheela Ashfaq; Volkan Adsay; Suzanne J Baker; Virginia Valentine; Paula M Hempen; Werner Hilgers; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.

Authors:  Ali R Shekouh; Christopher C Thompson; Wendy Prime; Fiona Campbell; Jane Hamlett; C Simon Herrington; Nicholas R Lemoine; Tatjana Crnogorac-Jurcevic; Markus W Buechler; Helmut Friess; John P Neoptolemos; Stephen R Pennington; Eithne Costello
Journal:  Proteomics       Date:  2003-10       Impact factor: 3.984

View more
  7 in total

1.  Precise inference of copy number alterations in tumor samples from SNP arrays.

Authors:  Gary K Chen; Xiao Chang; Christina Curtis; Kai Wang
Journal:  Bioinformatics       Date:  2013-09-09       Impact factor: 6.937

2.  Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length.

Authors:  Ming-Tseh Lin; Li-Hui Tseng; Hirohiko Kamiyama; Mihoko Kamiyama; Phillip Lim; Manuel Hidalgo; Sarah Wheelan; James Eshleman
Journal:  Biotechniques       Date:  2010-03       Impact factor: 1.993

3.  Advancing a clinically relevant perspective of the clonal nature of cancer.

Authors:  Christian Ruiz; Elizabeth Lenkiewicz; Lisa Evers; Tara Holley; Alex Robeson; Jeffrey Kiefer; Michael J Demeure; Michael A Hollingsworth; Michael Shen; Donna Prunkard; Peter S Rabinovitch; Tobias Zellweger; Spyro Mousses; Jeffrey M Trent; John D Carpten; Lukas Bubendorf; Daniel Von Hoff; Michael T Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

Review 4.  PhyloOncology: Understanding cancer through phylogenetic analysis.

Authors:  Jason A Somarelli; Kathryn E Ware; Rumen Kostadinov; Jeffrey M Robinson; Hakima Amri; Mones Abu-Asab; Nicolaas Fourie; Rui Diogo; David Swofford; Jeffrey P Townsend
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-10-31       Impact factor: 11.414

5.  SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.

Authors:  N L E Harris; C Vennin; J R W Conway; K L Vine; M Pinese; M J Cowley; R F Shearer; M C Lucas; D Herrmann; A H Allam; M Pajic; J P Morton; A V Biankin; M Ranson; P Timpson; D N Saunders
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

6.  Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer.

Authors:  Karl Roland Ehrenberg; Jianpeng Gao; Felix Oppel; Stephanie Frank; Na Kang; Sebastian M Dieter; Friederike Herbst; Lino Möhrmann; Taronish D Dubash; Erik R Schulz; Hendrik Strakerjahn; Klara M Giessler; Sarah Weber; Ava Oberlack; Eva-Maria Rief; Oliver Strobel; Frank Bergmann; Felix Lasitschka; Jürgen Weitz; Hanno Glimm; Claudia R Ball
Journal:  Cells       Date:  2019-02-10       Impact factor: 6.600

7.  Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine.

Authors:  Jun Yu; Kimberly Walter; Noriyuki Omura; Seung-Mo Hong; Angela Young; Ang Li; Audrey Vincent; Michael Goggins
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.